Gynecologic Oncology Group [clinicaltrials_resource:ae9c0f8d700a9cdb2018c9197ec22bf2]
Brian Slomovitz [clinicaltrials_resource:01ec9486d6088147110d52f4aff6f37c]Laura Havrilesky [clinicaltrials_resource:0428e057265caefdbf05f30b66cac37d]Jubilee Brown [clinicaltrials_resource:05626d3c6d4d85c20d5b84d0b5a2e3fb]Shu-Yuan Liao [clinicaltrials_resource:057f8f06e8a205c65b9070769cc91884]Robert Coleman [clinicaltrials_resource:06bdf05b532bdc991e9bc1aee42b64bf]Michael Gold [clinicaltrials_resource:06da4dd60708e4ab027e10ba29563671]Peter Rose [clinicaltrials_resource:08308de19afc5fa0aedf7c0c31a7e482]Allan Covens [clinicaltrials_resource:0933a82b1fad40a374dc2a1d340c1424]Brian Slomovitz, MD [clinicaltrials_resource:0f4ca83e40eace014df447411fb4b29e]Brian Slomovitz, MD [clinicaltrials_resource:13f4cd76d9266ab3d9f96d8b5429c92b]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Edwin Alvarez [clinicaltrials_resource:15d204188b170e4a0a8822a10a28b2dd]Katherine Look [clinicaltrials_resource:1853514218f6ad8943e0af7a4155afa0]Israel Zighelboim [clinicaltrials_resource:18a3e467b3714d5a5ec4027645632013]Tatyana Grushko [clinicaltrials_resource:1a51f9bb186124b5eb05898b9ea8be81]David Gershenson [clinicaltrials_resource:1ea6db415d7182681cb887c553f7b77e]Lainie Martin [clinicaltrials_resource:202642535968bd0aec6809fa4c242c81]Lisa Hess [clinicaltrials_resource:296bd024716d0e86c6e763b6e8fe64f7]Lydia Usha [clinicaltrials_resource:2b2cb82ae693ea3017bada60935c06fc]Robert Coleman [clinicaltrials_resource:2b700f2f365c7f35f0101662dca05395]Laura Havrilesky [clinicaltrials_resource:2d619574f4d64cfbb8f2b6c178e4d5f9]Janet Rader [clinicaltrials_resource:2e32dc4126ade8e95893e051ecc7b19e]Jeffrey Fowler [clinicaltrials_resource:33135b5bd2c35e831bf07ada3a4cb1db]Michael Method [clinicaltrials_resource:362d20f9739c692586623e9f2f00cec8]Brian Slomovitz, MD [clinicaltrials_resource:36cd08db61a7eae2e803299dedf537de]Bradley Monk [clinicaltrials_resource:36e3bb5f34d7408b2104d66e2a76422e]Martee Hensley [clinicaltrials_resource:396f15d31517d3339df9493b876d47c1]Shu-Yuan Liao [clinicaltrials_resource:3a4ffdc6d4877193e313249c54a86430]Laura Havrilesky [clinicaltrials_resource:3bec873425c1055b07f57dc9f8d63383]Robert Edwards [clinicaltrials_resource:3d7b244a5535ad07efd5f58c08e04ae1]Susan Modesitt [clinicaltrials_resource:4b1e62fc0da2d15f9762703dcb084871]Mark Morgan [clinicaltrials_resource:4c458f435943cd5eed294fb53dd92d00]Mark Greene [clinicaltrials_resource:5009e2853d6db77d5aae829ea7ee0a4b]Bradley Monk [clinicaltrials_resource:50c52a787953444f4526665a261be316]D. Scott McMeekin [clinicaltrials_resource:51fd3003759acd4bdacc1b98c5d6620e]Julian Schink [clinicaltrials_resource:52168cfed50acd5a46e325784f856ca9]Daniela Matei [clinicaltrials_resource:52fd0e5e9bfae746a55452e2303396ac]Sang Ryu [clinicaltrials_resource:541317bc069fcae15c7b241a35c266aa]Alessandro Santin [clinicaltrials_resource:55435c7880fba4971541529ef38d5552]Lydia Usha [clinicaltrials_resource:55fbda8a984d4a2f0738ca57717318da]
affiliation [clinicaltrials_vocabulary:affiliation]
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer [clinicaltrials:NCT00002478]Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer [clinicaltrials:NCT00002493]Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer [clinicaltrials:NCT00002536]Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers [clinicaltrials:NCT00002538]Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus [clinicaltrials:NCT00002546]Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer [clinicaltrials:NCT00002562]Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer [clinicaltrials:NCT00002568]Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus [clinicaltrials:NCT00002706]Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00002717]Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer [clinicaltrials:NCT00002813]Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer [clinicaltrials:NCT00002819]Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer [clinicaltrials:NCT00002976]Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus [clinicaltrials:NCT00002993]Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus [clinicaltrials:NCT00003054]Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix [clinicaltrials:NCT00003078]Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus [clinicaltrials:NCT00003128]Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus [clinicaltrials:NCT00003156]Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer [clinicaltrials:NCT00003179]Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus [clinicaltrials:NCT00003316]Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer [clinicaltrials:NCT00003322]Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva [clinicaltrials:NCT00003325]clinicaltrials:NCT00003377Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer [clinicaltrials:NCT00003378]Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer [clinicaltrials:NCT00003379]Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00003380]Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [clinicaltrials:NCT00003382]Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer [clinicaltrials:NCT00003384]Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00003385]Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [clinicaltrials:NCT00003386]Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum [clinicaltrials:NCT00003523]Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [clinicaltrials:NCT00003624]clinicaltrials:NCT00003644Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia [clinicaltrials:NCT00003688]Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [clinicaltrials:NCT00003691]Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia [clinicaltrials:NCT00003702]Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer [clinicaltrials:NCT00003794]Quality of Life in Survivors of Gynecologic Cancer [clinicaltrials:NCT00003795]Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer [clinicaltrials:NCT00003945]Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer [clinicaltrials:NCT00003946]Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00003967]
collaborator [clinicaltrials_vocabulary:collaborator]
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer [clinicaltrials:NCT00002478]Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer [clinicaltrials:NCT00002493]Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer [clinicaltrials:NCT00002536]Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers [clinicaltrials:NCT00002538]Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus [clinicaltrials:NCT00002546]Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer [clinicaltrials:NCT00002562]Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer [clinicaltrials:NCT00002568]Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus [clinicaltrials:NCT00002706]Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00002717]Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer [clinicaltrials:NCT00002813]Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer [clinicaltrials:NCT00002819]Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer [clinicaltrials:NCT00002976]Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus [clinicaltrials:NCT00002993]Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus [clinicaltrials:NCT00003054]Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix [clinicaltrials:NCT00003078]Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus [clinicaltrials:NCT00003128]Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus [clinicaltrials:NCT00003156]Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer [clinicaltrials:NCT00003179]Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus [clinicaltrials:NCT00003316]Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer [clinicaltrials:NCT00003322]Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva [clinicaltrials:NCT00003325]clinicaltrials:NCT00003377Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer [clinicaltrials:NCT00003378]Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer [clinicaltrials:NCT00003379]Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00003380]Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [clinicaltrials:NCT00003382]Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer [clinicaltrials:NCT00003384]Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00003385]Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [clinicaltrials:NCT00003386]Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum [clinicaltrials:NCT00003523]Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [clinicaltrials:NCT00003624]clinicaltrials:NCT00003644Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia [clinicaltrials:NCT00003688]Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [clinicaltrials:NCT00003691]Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia [clinicaltrials:NCT00003702]Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer [clinicaltrials:NCT00003794]Quality of Life in Survivors of Gynecologic Cancer [clinicaltrials:NCT00003795]Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer [clinicaltrials:NCT00003945]Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer [clinicaltrials:NCT00003946]Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00003967]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer [clinicaltrials:NCT00002478]Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer [clinicaltrials:NCT00002493]Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer [clinicaltrials:NCT00002536]Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal Cancers [clinicaltrials:NCT00002538]Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the Uterus [clinicaltrials:NCT00002546]Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer [clinicaltrials:NCT00002568]Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus [clinicaltrials:NCT00002706]Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer [clinicaltrials:NCT00002717]Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer [clinicaltrials:NCT00002813]Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial Cancer [clinicaltrials:NCT00002819]Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer [clinicaltrials:NCT00002976]Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus [clinicaltrials:NCT00002993]Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus [clinicaltrials:NCT00003054]Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix [clinicaltrials:NCT00003078]Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the Uterus [clinicaltrials:NCT00003128]Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus [clinicaltrials:NCT00003156]Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer [clinicaltrials:NCT00003179]Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus [clinicaltrials:NCT00003316]Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer [clinicaltrials:NCT00003322]Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva [clinicaltrials:NCT00003325]clinicaltrials:NCT00003377Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer [clinicaltrials:NCT00003378]Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer [clinicaltrials:NCT00003379]Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer [clinicaltrials:NCT00003380]Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube Cancer [clinicaltrials:NCT00003382]Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer [clinicaltrials:NCT00003384]Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00003385]Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer [clinicaltrials:NCT00003386]Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [clinicaltrials:NCT00003624]clinicaltrials:NCT00003644Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia [clinicaltrials:NCT00003688]Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer [clinicaltrials:NCT00003691]Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia [clinicaltrials:NCT00003702]Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer [clinicaltrials:NCT00003794]Quality of Life in Survivors of Gynecologic Cancer [clinicaltrials:NCT00003795]Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer [clinicaltrials:NCT00003945]Danazol in Treating Patients With Advanced or Recurrent Endometrial Cancer [clinicaltrials:NCT00003946]Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00003967]Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer [clinicaltrials:NCT00004037]Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian Cancer [clinicaltrials:NCT00004221]
source [clinicaltrials_vocabulary:source]
Gynecologic Oncology Group [clinicaltrials_resource:ae9c0f8d700a9cdb2018c9197ec22bf2]
Bio2RDF identifier
ae9c0f8d700a9cdb2018c9197ec22bf2
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ae9c0f8d700a9cdb2018c9197ec22bf2
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:ae9c0f8d700a9cdb2018c9197ec22bf2
title
Gynecologic Oncology Group
@en
type
label
Gynecologic Oncology Group [clinicaltrials_resource:ae9c0f8d700a9cdb2018c9197ec22bf2]
@en